Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Pe Benjamin Manlaui — Durata Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Pe Benjamin Manlaui

Pe Benjamin Manlaui

10% owner at Durata Therapeutics, Inc. · on record since Jul 18, 2012
Former 10% Owner at Durata Therapeutics, Inc. · on record since Feb 14, 2013

Insider trading activity of Pe Benjamin Manlaui

Transactions on record: 1; since Feb 14, 2013

Open-market buys: 1; $45K

Open-market sells: 0

Companies traded: 1; last filing Feb 14, 2013

Figures computed from official regulatory filings — methodology.

Companies where Pe Benjamin Manlaui has traded

Durata Therapeutics, Inc.1 tx · $45K · Feb 14, 2013

Track record of Pe Benjamin Manlaui

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Pe Benjamin Manlaui

Co-insiders of Pe Benjamin Manlaui

Ahrens Brenton KarlDurata Therapeutics, Inc.
AISLING CAPITAL III LPDurata Therapeutics, Inc.
Aisling Capital Partners III LLCDurata Therapeutics, Inc.
Aisling Capital Partners III LPDurata Therapeutics, Inc.
AKKARAJU SRINIVASDurata Therapeutics, Inc.
Allen Susan RobertaDurata Therapeutics, Inc.
Birchler Angela GurskiDurata Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BLAIR JAMES CDurata Therapeutics, Inc.

Buatois EricDurata Therapeutics, Inc.

Canaan Management, Inc.Durata Therapeutics, Inc.

Canaan Partners VIII LLCDurata Therapeutics, Inc.

Canaan VIII LPDurata Therapeutics, Inc.

CARROLL J MARTINDurata Therapeutics, Inc.

CHAMBON PHILIPPEDurata Therapeutics, Inc.

Delagardelle JeaniDurata Therapeutics, Inc.

DE SCHUTTER RICHARD UDurata Therapeutics, Inc.

DOMAIN ASSOCIATESDurata Therapeutics, Inc.

Domain Partners VIII, L.P.Durata Therapeutics, Inc.

DOVEY BRIAN HDurata Therapeutics, Inc.

DP VIII Associates, L.P.Durata Therapeutics, Inc.

Dunne Michael W.Durata Therapeutics, Inc.

Edick Paul RDurata Therapeutics, Inc.

ELMS STEVEDurata Therapeutics, Inc.

Fishman Corey N.Durata Therapeutics, Inc.

FRIEDMAN PAUL ADurata Therapeutics, Inc.

Giles Lisa M.Durata Therapeutics, Inc.

GOLDSTEIN DOV A MDDurata Therapeutics, Inc.

Halak Brian KDurata Therapeutics, Inc.

HEALY JAMESDurata Therapeutics, Inc.

HORNER GEORGE F IIIDurata Therapeutics, Inc.

HUNT RONALDDurata Therapeutics, Inc.

Kamdar Kim P.Durata Therapeutics, Inc.

Kovacevic MilanDurata Therapeutics, Inc.

Lack Jeremy DavidDurata Therapeutics, Inc.

Lathi Vijay KDurata Therapeutics, Inc.

New Leaf Venture Associates II, L.P.Durata Therapeutics, Inc.

New Leaf Venture Management II, L.L.C.Durata Therapeutics, Inc.

New Leaf Ventures II, L.P.Durata Therapeutics, Inc.

NIEDEL JAMESDurata Therapeutics, Inc.

OBOYLE KEVIN CDurata Therapeutics, Inc.

POWELL MICHAELDurata Therapeutics, Inc.

Purcell Dennis JDurata Therapeutics, Inc.

Ratcliffe LiamDurata Therapeutics, Inc.

SCHIFF ANDREW NDurata Therapeutics, Inc.

SCHOEMAKER KATHLEEN KDurata Therapeutics, Inc.

Shannon John Patrick JrDurata Therapeutics, Inc.

Sofinnova Management VII, L.L.C.Durata Therapeutics, Inc.

SOFINNOVA VENTURE PARTNERS VII L PDurata Therapeutics, Inc.

Talbot George HarrisonDurata Therapeutics, Inc.

TREU JESSE IDurata Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Durata Therapeutics, Inc.	Feb 14, 2013	Buy	5,000	9.00 USD	$45K	SEC